Agenus Stock News

A long-awaited regulatory event sent the biotech's shares on a roller-coaster ride last year.

A long-awaited regulatory event sent the biotech's shares on a roller-coaster ride last year.

Investors need to pay close attention to Agenus (AGEN) stock based on the movements in the options market lately.

Agenus (AGEN) announced that Dr. Jennifer Buell, its President and Chief Operating Officer, resigned from her position at the company to become President and Chief Executive Officer at

LEXINGTON, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activat

LEXINGTON, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activate

Related Stocks: ARGX , MGNX , CUTR , RNA , FULC , ITOS , TMO , PEN , TNYA , SGHT , AADI , RCOR , PTGX , MDXG , CSTL , AGEN , ABUS , QDEL , TRIL , CHAQ , BCTG , ITMR , RACA ,

Agenus Inc. (NASDAQ:AGEN) traded at $3.52 at close of the session on Tuesday, 12/21/21, made a downward move of -0.28% on its previous days price. Looking at the stock we see that its previous close was $3.53 and the beta (5Y monthly) reads 1.40 with the days price range being $3.41 $3.56. In terms Investors Take Advantage Of -0.28% Loss In Agenus Inc. (NASDAQ: AGEN) Read More »

LEXINGTON, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activa

Wall Street analysts expect that Agenus Inc. (NASDAQ:AGEN) will report earnings of ($0.12) per share for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Agenus earnings. The highest EPS estimate is ($0.04) and the lowest is ($0.16). Agenus reported earnings per share of ($0.20) in the same quarter last year, [] The post -$0.12 Earnings Per Share Expected for Agenus Inc. (NASDAQ:AGEN) This Quarter appeared first on ETF Daily News .

Agenus Inc. (NASDAQ:AGEN) price closed higher on Tuesday, December 07, jumping 6.60% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

A mix of marketwide headwinds and company-specific events weighed on these three biotech stocks in November.

A mix of marketwide headwinds and company-specific events weighed on these three biotech stocks in November.

Wall Street analysts expect that Agenus Inc. (NASDAQ:AGEN) will report earnings of ($0.12) per share for the current quarter, according to Zacks. Three analysts have provided estimates for Agenus earnings. The lowest EPS estimate is ($0.16) and the highest is ($0.04). Agenus reported earnings of ($0.20) per share in the same quarter last year, which []